查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941492

基因組學市場規模、佔有率和趨勢分析報告：按應用、產品、最終用途、地區和細分市場預測（2026-2033 年）

Genomics Market Size, Share & Trends Analysis Report By Application (Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery), By Deliverables (Products, Services), By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

基因組學市場概覽

全球基因組學市場預計到 2025 年將價值 217.6 億美元，預計到 2033 年將達到 725 億美元。

預計從 2026 年到 2033 年，該行業將以 18.2% 的複合年成長率成長。這一成長得益於新興基因組學應用，這些應用能夠實現先進的基因設計、通道工程以及醫療保健、工業生物技術和研究應用領域的數據驅動型生物創新。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場趨勢與展望
  • 市場動態
  • 市場限制因素分析
    • 基因組技術的高成本
  • 產業分析工具
    • PESTLE分析
    • 波特五力分析

第4章 應用業務分析

  • 全球基因組學市場：應用變異分析
  • 全球基因體學市場規模及趨勢分析（按應用領域分類，2021-2033 年）
  • 功能基因體學
    • 功能基因體學市場，2021-2033年
    • 即時PCR
    • 轉染
    • SNP分析
    • 突變分析
    • 微陣列分析
    • RNA干擾
  • 表觀基因
    • 表觀基因市場，2021-2033年
    • 亞硫酸氫鹽序列
    • 微陣列分析
    • 染色質免疫沉澱分析法（ChIP 和 ChIP-Seq）
    • 甲基化DNA免疫沉澱分析法（MeDIP）
    • 高解析度裂解（HRM）
    • 染色質可及性分析
  • 通路分析
    • 通路分析市場，2021-2033年
    • 微陣列分析
    • 以微珠為基礎的分析
    • 蛋白質體學工具（2D電泳、酵母雙雜交法）
    • 即時PCR
  • 生物標記發現
    • 生物標記發現市場，2021-2033年
    • DNA定序
    • 微陣列分析
    • 即時PCR
    • 質譜分析
    • 統計分析
    • 生物資訊學
  • 其他

第5章：依交付成果進行業務分析

  • 全球基因組學市場：產品變異分析
  • 全球基因體學市場規模及趨勢分析（按產品分類，2021-2033 年）
  • 產品
    • 產品市場，2021-2033年
    • 設備系統軟體
    • 耗材和試劑
  • 服務
    • 服務市場，2021-2033年
    • 基於次世代定序 (NGS) 的服務
    • 核心基因組學服務
    • 生物標誌轉化服務
    • 計算服務
    • 其他

第6章 依最終用途進行業務分析

  • 全球基因組學市場：最終用途變異分析
  • 全球基因體學市場規模及趨勢分析（依最終用途分類，2021-2033年）
  • 製藥和生物技術公司
  • 醫院和診所
  • 學術和政府機構
  • 臨床研究
  • 其他

第7章 區域業務分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 北美基因體學市場，2021-2033年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲基因體學市場，2021-2033年
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太基因組學市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲基因體學市場，2021-2033年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲基因組學市場，2021-2033年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與企業
  • 策略規劃
  • 企業市場分析（2025 年）
  • 參與公司概況
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd.
    • Agilent Technologies
    • BGI Genomics
    • QIAGEN NV
    • Oxford Nanopore Technologies
    • PacBio.
    • Bio-Rad Laboratories, Inc.
Product Code: 978-1-68038-188-7

Genomics Market Summary

The global genomics market size was estimated at USD 21.76 billion in 2025 and is projected to reach USD 72.50 billion by 2033, growing at a CAGR of 18.2% from 2026 to 2033. This growth is supported by emerging genomics applications, which enable advanced genetic design, pathway engineering, and data-driven biological innovation across healthcare, industrial biotechnology, and research applications.

Global Genomics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global genomics market report based on application, deliverables, end-use, and region.

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Functional Genomics
    • Real-time PCR
    • Transfection
    • SNP Analysis
    • Mutational Analysis
    • Microarray Analysis
    • RNA Interference
  • Epigenomics
    • Bisulfite Sequencing
    • Microarray Analysis
    • Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
    • Methylated DNA Immunoprecipitation (MeDIP)
    • High Resolution Melt (HRM)
    • Chromatin Accessibility Assays
  • Pathway Analysis
    • Microarray Analysis
    • Bead-based Analysis
    • Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
    • Real-time PCR
  • Biomarker Discovery
    • DNA Sequencing
    • Microarray Analysis
    • Real-time PCR
    • Mass Spectrometry
    • Statistical Analysis
    • Bioinformatics
  • Others
  • Deliverables Outlook (Revenue, USD Million, 2021 - 2033)
  • Products
    • Instruments/Systems/Software
    • Consumables & Reagents
  • Services
    • NGS-based Services
    • Core Genomics Services
    • Biomarker Translation Services
    • Computational Services
    • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Government Institutes
  • Clinical Research
  • Other End Users
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwaita

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Application Segment
    • 1.2.2. Deliverables Segment
    • 1.2.3. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Rapid Technological Advancements
    • 3.3.2. Precision Medicine & Personalized Healthcare
  • 3.4. Market Restraint Analysis
    • 3.4.1. High Cost of Genomics Technologies
  • 3.5. Industry Analysis Tools
    • 3.5.1. PESTLE Analysis
    • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Application Business Analysis

  • 4.1. Application Segment Dashboard
  • 4.2. Global Genomics Market: Application Movement Analysis
  • 4.3. Global Genomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Functional Genomics
    • 4.4.1. Functional Genomics Market, 2021 - 2033 (USD Million)
    • 4.4.2. Real-time PCR
      • 4.4.2.1. Real-time PCR Market, 2021 - 2033 (USD Million)
    • 4.4.3. Transfection
      • 4.4.3.1. Transfection Market, 2021 - 2033 (USD Million)
    • 4.4.4. SNP Analysis
      • 4.4.4.1. SNP Analysis Market, 2021 - 2033 (USD Million)
    • 4.4.5. Mutational Analysis
      • 4.4.5.1. Mutational Analysis Market, 2021 - 2033 (USD Million)
    • 4.4.6. Microarray Analysis
      • 4.4.6.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
    • 4.4.7. RNA Interference
      • 4.4.7.1. RNA Interference Market, 2021 - 2033 (USD Million)
  • 4.5. Epigenomics
    • 4.5.1. Epigenomics Market, 2021 - 2033 (USD Million)
    • 4.5.2. Bisulfite Sequencing
      • 4.5.2.1. Bisulfite Sequencing Market, 2021 - 2033 (USD Million)
    • 4.5.3. Microarray Analysis
      • 4.5.3.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
    • 4.5.4. Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
      • 4.5.4.1. Chromatin Immunoprecipitation (ChIP & ChIP-Seq) Market, 2021 - 2033 (USD Million)
    • 4.5.5. Methylated DNA Immunoprecipitation (MeDIP)
      • 4.5.5.1. Methylated DNA Immunoprecipitation (MeDIP) Market, 2021 - 2033 (USD Million)
    • 4.5.6. High Resolution Melt (HRM)
      • 4.5.6.1. High Resolution Melt (HRM) Market, 2021 - 2033 (USD Million)
    • 4.5.7. Chromatin Accessibility Assays
      • 4.5.7.1. Chromatin Accessibility Assays Market, 2021 - 2033 (USD Million)
  • 4.6. Pathway Analysis
    • 4.6.1. Pathway Analysis Market, 2021 - 2033 (USD Million)
    • 4.6.2. Microarray Analysis
      • 4.6.2.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
    • 4.6.3. Bead-based Analysis
      • 4.6.3.1. Bead-based Analysis Market, 2021 - 2033 (USD Million)
    • 4.6.4. Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
      • 4.6.4.1. Proteomics Tools (2-D PAGE; yeast 2-hybrid studies) Market, 2021 - 2033 (USD Million)
    • 4.6.5. Real-time PCR
      • 4.6.5.1. Real-time PCR Market, 2021 - 2033 (USD Million)
  • 4.7. Biomarker Discovery
    • 4.7.1. Biomarker Discovery Market, 2021 - 2033 (USD Million)
    • 4.7.2. DNA Sequencing
      • 4.7.2.1. DNA Sequencing Market, 2021 - 2033 (USD Million)
    • 4.7.3. Microarray Analysis
      • 4.7.3.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
    • 4.7.4. Real-time PCR
      • 4.7.4.1. Real-time PCR Market, 2021 - 2033 (USD Million)
    • 4.7.5. Mass Spectrometry
      • 4.7.5.1. Mass Spectrometry Market, 2021 - 2033 (USD Million)
    • 4.7.6. Statistical Analysis
      • 4.7.6.1. Statistical Analysis Market, 2021 - 2033 (USD Million)
    • 4.7.7. Bioinformatics
      • 4.7.7.1. Bioinformatics Market, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Deliverables Business Analysis

  • 5.1. Deliverables Segment Dashboard
  • 5.2. Global Genomics Market: Deliverables Movement Analysis
  • 5.3. Global Genomics Market Size & Trend Analysis, by Deliverables, 2021 to 2033 (USD Million)
  • 5.4. Products
    • 5.4.1. Products Market, 2021 - 2033 (USD Million)
    • 5.4.2. Instruments/Systems/Software
      • 5.4.2.1. Instruments/Systems/Software Market, 2021 - 2033 (USD Million)
    • 5.4.3. Consumables & Reagents
      • 5.4.3.1. Consumables & Reagents Market, 2021 - 2033 (USD Million)
  • 5.5. Services
    • 5.5.1. Services Market, 2021 - 2033 (USD Million)
    • 5.5.2. NGS-based Services
      • 5.5.2.1. NGS-based Services Market, 2021 - 2033 (USD Million)
    • 5.5.3. Core Genomics Services
      • 5.5.3.1. Core Genomics Services Market, 2021 - 2033 (USD Million)
    • 5.5.4. Biomarker Translation Services
      • 5.5.4.1. Biomarker Translation Services Market, 2021 - 2033 (USD Million)
    • 5.5.5. Computational Services
      • 5.5.5.1. Computational Services Market, 2021 - 2033 (USD Million)
    • 5.5.6. Others
      • 5.5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Genomics Market: End Use Movement Analysis
  • 6.3. Global Genomics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical and Biotechnology Companies
    • 6.4.1. Pharmaceutical and Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 6.5. Hospitals and Clinics
    • 6.5.1. Hospitals and Clinics Market, 2021 - 2033 (USD Million)
  • 6.6. Academic and Government Institutes
    • 6.6.1. Academic and Government Institutes Market, 2021 - 2033 (USD Million)
  • 6.7. Clinical Research
    • 6.7.1. Clinical Research Market, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America Genomics Market, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Genomics Market, 2021 - 2033 (USD MILLION)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Genomics Market, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Genomics Market, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Genomics Market, 2021 - 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Germany Genomics Market, 2021 - 2033 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. UK Genomics Market, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Genomics Market, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Genomics Market, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Genomics Market, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Genomics Market, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Genomics Market, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Genomics Market, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Genomics Market, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Genomics Market, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Genomics Market, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Genomics Market, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. South Korea Genomics Market, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Australia Genomics Market, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Thailand Genomics Market, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Genomics Market, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Genomics Market, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Genomics Market, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Genomics Market, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Genomics Market, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Genomics Market, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Genomics Market, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Genomics Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Participant's Overview
    • 8.4.1. Illumina, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Danaher Corporation
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. F. Hoffmann-La Roche Ltd.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Agilent Technologies
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. BGI Genomics
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. QIAGEN N.V.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Oxford Nanopore Technologies
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. PacBio.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Bio-Rad Laboratories, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 4 Global Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 6 Global Genomics Market, by Region, 2021 - 2033 (USD Million)
  • Table 7 North America Genomics Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 9 North America Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 10 North America Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 12 U.S. Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 13 U.S. Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 15 Canada Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 16 Canada Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 18 Mexico Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 19 Mexico Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Genomics Market, by Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 22 Europe Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Europe Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 24 Germany Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 25 Germany Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 26 Germany Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 27 UK Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 28 UK Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 29 UK Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 30 France Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 31 France Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 32 France Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 34 Italy Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 35 Italy Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 37 Spain Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 38 Spain Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 39 Denmark Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 40 Denmark Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 41 Denmark Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 42 Sweden Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 43 Sweden Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 44 Sweden Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 45 Norway Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 46 Norway Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 47 Norway Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Genomics Market, by Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 52 China Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 53 China Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 54 China Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 55 Japan Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 56 Japan Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 57 Japan Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 58 India Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 59 India Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 60 India Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 61 South Korea Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 62 South Korea Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 63 South Korea Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 64 Australia Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 65 Australia Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 66 Australia Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 67 Thailand Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 68 Thailand Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 69 Thailand Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 70 Latin America Genomics Market, by Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 72 Latin America Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 73 Latin America Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 75 Brazil Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 76 Brazil Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 78 Argentina Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 79 Argentina Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Genomics Market, by Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 84 South Africa Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 85 South Africa Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 86 South Africa Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 90 UAE Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 91 UAE Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 92 UAE Genomics Market, End Use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Genomics Market, by Deliverables, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Genomics Market, by Application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Genomics Market, End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Genomics Market Segmentation
  • Fig. 6 Market Snapshot, 2025
  • Fig. 7 Market Trends & Outlook
  • Fig. 8 Market Driver Relevance Analysis
  • Fig. 9 Market Restraint Relevance Analysis
  • Fig. 10 PESTEL Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Global Genomics Market: Deliverables Key Takeaways
  • Fig. 13 Global Genomics Market: Deliverables Movement Analysis
  • Fig. 14 Global Genomics Market, for Products, 2021 - 2033 (USD Million)
  • Fig. 15 Global Genomics Market, for Instruments/Systems/Software, 2021 - 2033 (USD Million)
  • Fig. 16 Global Genomics Market, for Consumables & Reagents, 2021 - 2033 (USD Million)
  • Fig. 17 Global Genomics Market, for Services, 2021 - 2033 (USD Million)
  • Fig. 18 Global Genomics Market, for NGS-based Services, 2021 - 2033 (USD Million)
  • Fig. 19 Global Genomics Market, for Core Genomics Services, 2021 - 2033 (USD Million)
  • Fig. 20 Global Genomics Market, for Biomarker Translation Services, 2021 - 2033 (USD Million)
  • Fig. 21 Global Genomics Market, for Computational Services, 2021 - 2033 (USD Million)
  • Fig. 22 Global Genomics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 23 Global Genomics Market: Application Key Takeaways
  • Fig. 24 Global Genomics Market, Application Movement Analysis
  • Fig. 25 Global Genomics Market, for Functional Genomics, 2021 - 2033 (USD Million)
  • Fig. 26 Global Genomics Market, for Real-time PCR, 2021 - 2033 (USD Million)
  • Fig. 27 Global Genomics Market, for Transfection, 2021 - 2033 (USD Million)
  • Fig. 28 Global Genomics Market, for SNP Analysis, 2021 - 2033 (USD Million)
  • Fig. 29 Global Genomics Market, for Mutational Analysis, 2021 - 2033 (USD Million)
  • Fig. 30 Global Genomics Market, for Microarray Analysis, 2021 - 2033 (USD Million)
  • Fig. 31 Global Genomics Market, for RNA Interference, 2021 - 2033 (USD Million)
  • Fig. 32 Global Genomics Market, for Epigenomics, 2021 - 2033 (USD Million)
  • Fig. 33 Global Genomics Market, for Bisulfite Sequencing, 2021 - 2033 (USD Million)
  • Fig. 34 Global Genomics Market, for Microarray Analysis, 2021 - 2033 (USD Million)
  • Fig. 35 Global Genomics Market, for Functional Genomics, 2021 - 2033 (USD Million)
  • Fig. 36 Global Genomics Market, for Chromatin Immunoprecipitation (ChIP & ChIP-Seq), 2021 - 2033 (USD Million)
  • Fig. 37 Global Genomics Market, for Methylated DNA Immunoprecipitation (MeDIP), 2021 - 2033 (USD Million)
  • Fig. 38 Global Genomics Market, for High Resolution Melt (HRM), 2021 - 2033 (USD Million)
  • Fig. 39 Global Genomics Market, for Chromatin Accessibility Assays, 2021 - 2033 (USD Million)
  • Fig. 40 Global Genomics Market, for Pathway Analysis, 2021 - 2033 (USD Million)
  • Fig. 41 Global Genomics Market, for Microarray Analysis, 2021 - 2033 (USD Million)
  • Fig. 42 Global Genomics Market, for RNA Interference, 2021 - 2033 (USD Million)
  • Fig. 43 Global Genomics Market, for Bead-based Analysis, 2021 - 2033 (USD Million)
  • Fig. 44 Global Genomics Market, for Proteomics Tools (2-D PAGE; yeast 2-hybrid studies), 2021 - 2033 (USD Million)
  • Fig. 45 Global Genomics Market, for Real-time PCR, 2021 - 2033 (USD Million)
  • Fig. 46 Global Genomics Market, for Biomarker Discovery, 2021 - 2033 (USD Million)
  • Fig. 47 Global Genomics Market, for DNA Sequencing, 2021 - 2033 (USD Million)
  • Fig. 48 Global Genomics Market, for Microarray Analysis, 2021 - 2033 (USD Million)
  • Fig. 49 Global Genomics Market, for Real-time PCR, 2021 - 2033 (USD Million)
  • Fig. 50 Global Genomics Market, for Mass Spectrometry, 2021 - 2033 (USD Million)
  • Fig. 51 Global Genomics Market, for Statistical Analysis, 2021 - 2033 (USD Million)
  • Fig. 52 Global Genomics Market, for Bioinformatics, 2021 - 2033 (USD Million)
  • Fig. 53 Global Genomics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 54 Global Genomics Market: End Use Movement Analysis
  • Fig. 55 Global Genomics Market, for Pharmaceutical and Biotechnology Companies, 2021 - 2033 (USD Million)
  • Fig. 56 Global Genomics Market, for Hospitals and Clinics, 2021 - 2033 (USD Million)
  • Fig. 57 Global Genomics Market, for Academic and Government Institutes, 2021 - 2033 (USD Million)
  • Fig. 58 Global Genomics Market, for Clinical Research, 2021 - 2033 (USD Million)
  • Fig. 59 Global Genomics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 60 Regional Marketplace: Key Takeaways
  • Fig. 61 Regional Outlook, 2025 & 2033
  • Fig. 62 North America Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 63 U.S. Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 64 Canada Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 65 Mexico Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 66 Europe Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 67 Germany Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 68 UK Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 69 France Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 70 Italy Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 71 Spain Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 72 Denmark Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 73 Sweden Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 74 Norway Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 75 Asia Pacific Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 76 Japan Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 77 China Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 78 India Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 79 Australia Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 80 South Korea Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 81 Thailand Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 82 Latin America Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 83 Brazil Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 84 Argentina Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 85 Middle East and Africa Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 86 South Africa Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 87 Saudi Arabia Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 88 UAE Genomics Market, 2021 - 2033 (USD Million)
  • Fig. 89 Kuwait Genomics Market, 2021 - 2033 (USD Million)